Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Position Boosted by Dodge & Cox

Dodge & Cox grew its holdings in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 7.3% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 2,384,701 shares of the biopharmaceutical company’s stock after purchasing an additional 161,642 shares during […]

Related Keywords

Roberte Landry ,Christinea Poon , ,News Ratings For Regeneron Pharmaceuticals Daily ,Colonial River Wealth Management ,Nasdaq ,Exchange Commission ,Regeneron Pharmaceuticals Inc ,Mission Wealth Management ,Securities Exchange Commission ,Trifecta Capital Advisors ,Regeneron Pharmaceuticals ,Canaccord Genuity Group ,Wells Fargo Company ,Regeneron Pharmaceuticals Stock Performance ,Magnus Financial Group ,Insider Activity At Regeneron Pharmaceuticals ,Quarter For Regeneron Pharmaceuticals ,Barclays ,Free Report ,Street Advisors ,River Wealth Management ,Wealth Management ,Capital Advisors ,Financial Group ,Director Christine ,Get Free Report ,Visit Holdingschannel ,Regeneron Pharmaceuticals Daily ,Nasdaq Regn ,Regn ,Medical ,75886f10 ,Sec Filings ,13f ,Hedge Fund Holdings ,Institutional Investor Holdings ,